Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Research and Development Headed for Divorce

April 1, 2011

Research and development headed for divorce.

The Powerful Lesson of the GSK–Whistleblower Case

February 1, 2011

Those at the top must walk the walk of uncompromising commitment to compliance

The Case for Insourcing

January 1, 2011

Why this workforce trend is well-suited for pharmaceutical companies.

Biotech Writes its New "Play Book"

January 1, 2011

Business models that were used to create current value are no longer going to be effective going forward.

BioPharm International's 5th Annual Empolyment Survey

January 1, 2011

How did biopharmaceutical professionals fare during a year of hiring freezes, high anxiety, and increased workload? Our survey finds out.

Managing Raw Materials in the QbD Paradigm, Part 2: Risk Assessment and Communication

December 1, 2010

Evaluate and communicate risk to stakeholders.

Public–Private Partnerships: Life-Saving Mechanisms of Action

December 1, 2010

Managing partnerships for the greater good.

Getting Better at Making Stuff

December 1, 2010

To achieve manufacturing excellence, biopharma companies must adopt four key operating principles.

Biotech Cools Off as Capital Markets Weaken

October 1, 2010

Biotech's mid-sized elites position themselves for growth.



Click here